Optimal Management of Patients with Cancer-associated Venous Thromboembolism: The Important Role of Anticoagulation Therapy

Optimal Management of Patients with Cancer-associated Venous Thromboembolism: The Important Role of Anticoagulation Therapy is organized by Med Learning Group.

Release Date: June 20, 2022
Expiration Date: June 20, 2023

Program Overview:
This enduring activity will focus on the latest updates in the optimal management of cancer-associated venous thromboembolism (VTE) based on risk stratification, clinical trial data, and appropriate guideline-informed strategies to optimize clinical outcomes. This program will inform participants of the latest best practices as recommended by professional guidelines and will equip participants to integrate multidisciplinary care and shared decision-making in practice.

Learning Objectives:
Upon the completion of this program, attendees should be able to:
• Facilitate optimal management of patients with cancer-associated VTE based on risk stratification assessments
• Assess data from clinical trials supporting anticoagulants for the treatment of patients with cancer-associated VTE
• Select appropriate therapies for patients with cancer-associated VTE using recently updated evidence-based guidance from professional organizations
• Optimize outcomes for patients with cancer-associated VTE through the adoption of multidisciplinary patient-centered SDM management approaches